Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1994; 23:645-651
© 1994 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchant, B
Right arrow Articles by Timmis, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchant, B
Right arrow Articles by Timmis, A.

Reexamination of the role of endogenous opiates in silent myocardial ischemia

B Marchant, V Umachandran, P Wilkinson, S Medbak, PG Kopelman, and AD Timmis

Department of Cardiology, London Chest Hospital, England, United Kingdom.

OBJECTIVES. This study was designed to examine the role of beta-endorphin and met-enkephalin in the pathophysiology of silent myocardial ischemia, with emphasis on their role in the physiologic response to stress. BACKGROUND. Silent myocardial ischemia is more common in patients whose perception of pain is reduced. Whether endogenous opiates can contribute to this process remains uncertain largely because of the conflicting findings of previous studies. METHODS. Forty-three patients with coronary artery disease and ischemia on treadmill stress testing underwent electrical pain tests and exercise treadmill tests during naloxone and placebo infusion in a randomized, double-blind crossover study. Thirty-one patients developed angina during both treadmill tests (group A), and 12 had silent ischemia (group B). Plasma beta-endorphin, metenkephalin, epinephrine, norepinephrine and cortisol were measured before and after exercise in a subgroup of 17 patients. RESULTS. Naloxone reduced electrical pain tolerance (1.40 +/- 0.10 [mean +/- SEM] vs. 1.72 +/- 0.19 mA, p = 0.04) but did not affect the time to angina in group A (260 +/- 20 vs. 248 +/- 20 s, p = 0.72) or induce angina in group B patients. Beta-endorphin and met-enkephalin levels during placebo infusion were not significantly different in groups A and B at baseline and after exercise, although beta-endorphin levels were significantly increased during naloxone infusion, confirming effective opiate receptor blockade. Norepinephrine and cortisol increased with exercise, but catecholamines and cortisol were similar in both groups and were unaffected by naloxone. CONCLUSIONS. Beta-endorphin and met-enkephalin were similar in patients with painful and silent ischemia, and naloxone infusion did not influence anginal symptoms despite effective opiate receptor blockade and a reduction in somatic pain tolerance. These findings suggest that endogenous opiates do not play an important role in modulating symptoms in myocardial ischemia. The increase in beta-endorphin with exercise that coincided with an increase in plasma cortisol is most likely due to its release from the anterior pituitary gland as part of the physiologic stress response.


This article has been cited by other articles:


Home page
HeartHome page
N F Jarmukli, J Ahn, A Iranmanesh, and D C Russell
Effect of raised plasma beta endorphin concentrations on peripheral pain and angina thresholds in patients with stable angina
Heart, August 1, 1999; 82(2): 204 - 209.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Sheps, R. P. McMahon, K. C. Light, W. Maixner, C. J. Pepine, J. D. Cohen, A. D. Goldberg, R. Bonsall, R. Carney, P. H. Stone, et al.
Low hot pain threshold predicts shorter time to exercise-induced angina: results from the psychophysiological investigations of myocardial ischemia (PIMI) study
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1855 - 1862.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Tomai, F. Crea, A. Gaspardone, F. Versaci, A. S. Ghini, C. Ferri, G. Desideri, L. Chiariello, and P. A. Gioffre
Effects of naloxone on myocardial ischemic preconditioning in humans
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1863 - 1869.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement